In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Yichang HEC Changjiang Pharmaceutical Co. Ltd.

http://cj.hec.cn/en

Latest From Yichang HEC Changjiang Pharmaceutical Co. Ltd.

China Direct-Acting HCV Drug Race Rapidly Gathering Pace

After the recent approval of its first all-oral hepatitis C regimen, the China FDA is striving to approve within a year more direct-acting antiviral (DAA) therapies to treat all genotypes of the disease, setting the stage for both multinational and domestic pharma firms to compete in the world’s largest HCV drug market.

China Approvals

Start-Up Quarterly Statistics, Q4 2016

A review of biopharma start-up dealmaking and financing from October through December 2016, based on data from Strategic Transactions.

StartUps and SMEs Financing

Deals Shaping The Medical Industry, November 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in October 2016.

Deals Market Intelligence
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Infectious & Viral Diseases
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Parent & Subsidiaries
  • Yichang HEC Changjiang Pharmaceutical Co. Ltd.
  • Senior Management
  • Tang Xinfa, Chmn.
  • Contact Info
  • Yichang HEC Changjiang Pharmaceutical Co. Ltd.
    Phone: 769-81768886
    18/F, Tesbury Centre, 28 Queen’s Rd. E.
    Wanchai, Hong Kong
    China
Advertisement
Advertisement
UsernamePublicRestriction

Register